Symptom prevalence in advanced cancer: age, gender, and performance status interactions (Q48296622)

10 February 2018

title

Symptom prevalence in advanced cancer: age, gender, and performance status interactions (English)

1 reference

10 February 2018

author

Declan Walsh

3

1 reference

10 February 2018

author name string

Jordanka Kirkova

1

1 reference

10 February 2018

Lisa Rybicki

2

1 reference

10 February 2018

Aynur Aktas

4

1 reference

10 February 2018

publication date

21 June 2011

1 reference

10 February 2018

American Journal of Hospice and Palliative Medicine

published in

1 reference

10 February 2018

volume

29

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

page(s)

139-145

1 reference

10 February 2018

Symptom burden: multiple symptoms and their impact as patient-reported outcomes

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

A cytokine-based neuroimmunologic mechanism of cancer-related symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

Molecular interactions of cancer and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

21 January 2018

Cancer-related symptoms

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

Prevalence of anxiety and depression in cancer patients seen at the Norwegian Radium Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center: a role for symptom assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

The impact of age, treatment, and symptoms on the physical and mental health of cancer patients. A longitudinal perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

The course of symptom frequency and intensity in advanced cancer patients followed at home.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

Age group differences in psychological distress: the role of psychosocial risk factors that vary with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

Side effects of opioids during short-term administration: effect of age, gender, and race

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

Symptom prevalence, distress, and change over time in adults receiving treatment for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

Preliminary investigations of symptom distress in two cancer patient populations: evaluation of a measurement instrument

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

Toxicity and response criteria of the Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

Symptom correlates in the gero-oncology population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

Quality of life in advanced cancer patients: the impact of sociodemographic and medical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

The influence of increasing age on the deliverability and toxicity of fludarabine-based combination chemotherapy regimens in patients with indolent lymphoproliferative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

Sleep wake disturbances in people with cancer and their caregivers: state of the science

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

Symptom prevalence, characteristics and distress in a cancer population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

Intra and interobserver variability in cancer patients' performance status assessed according to Karnofsky and ECOG scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

Symptom clustering in advanced cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

21 January 2018

Depression and anxiety

1 reference

https://api.crossref.org/works/10.1177%2F1049909111410965

21 January 2018

Identifiers

DOI

10.1177/1049909111410965

1 reference

10 February 2018

1 reference

10 February 2018